These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 20489800)
21. [Australia antigen and viral hepatitis. Epidemiological study in blood donors]. Mansueto S; Tedesco V; Migneco G G Mal Infett Parassit; 1971 Dec; 23(12):1137-40. PubMed ID: 5004898 [No Abstract] [Full Text] [Related]
22. Specific inactivation of viruses which can potentially contaminate blood products. Horowitz B Dev Biol Stand; 1991; 75():43-52. PubMed ID: 1794631 [TBL] [Abstract][Full Text] [Related]
23. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria. Erhabor O; Ejele OA; Nwauche CA Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284 [TBL] [Abstract][Full Text] [Related]
29. Hepatitis-associated antigen in Belgium. Desmyter J; Liu W Arch Belg Med Soc; 1971 Jan; 29(1):1-10. PubMed ID: 5095938 [No Abstract] [Full Text] [Related]
30. [Transfusion hepatitis and inoculation hepatitis in the laboratory]. Stampfli K Med Lab (Stuttg); 1969 Aug; 22(8):178-86. PubMed ID: 5351057 [No Abstract] [Full Text] [Related]
31. Occult hepatitis B virus (HBV) infection in healthy blood donors. Duseja A; Sharma S; Subramanian PG; Agnihotri SK; Chakraborti A; Chawla Y Indian J Pathol Microbiol; 2003 Oct; 46(4):690-2. PubMed ID: 15025384 [TBL] [Abstract][Full Text] [Related]
32. Viral hepatitis--the state of the art. Clowdus BF Med Trial Tech Q; 1974; 21(1):63-75. PubMed ID: 4138562 [No Abstract] [Full Text] [Related]
33. Prevalence of transmissible blood infections among blood donors at the University of Maiducuri Teaching Hospital, Maiduguri, Nigeria. Chikwem JO; Mohammed I; Okara GC; Ukwandu NC; Ola TO East Afr Med J; 1997 Apr; 74(4):213-6. PubMed ID: 9299819 [TBL] [Abstract][Full Text] [Related]
34. The thymol turbidity test on donors' blood as a possible aid in control of the transmission of serum viral hepatitis. WEETH JB Brooklyn Hosp J; 1953; 11(4):193-7. PubMed ID: 13149941 [No Abstract] [Full Text] [Related]
35. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy. Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219 [TBL] [Abstract][Full Text] [Related]
36. Profile of transfusion transmissible infections and associated risk factors among blood donors of Kerala. Mathai J; Sulochana PV; Satyabhama S; Nair PK; Sivakumar S Indian J Pathol Microbiol; 2002 Jul; 45(3):319-22. PubMed ID: 12785175 [TBL] [Abstract][Full Text] [Related]
38. Risk factors for hepatitis C virus infection among blood donors in northern Thailand. Thaikruea L; Thongsawat S; Maneekarn N; Netski D; Thomas DL; Nelson KE Transfusion; 2004 Oct; 44(10):1433-40. PubMed ID: 15383015 [TBL] [Abstract][Full Text] [Related]
39. Controlling post-transfusion hepatitis: a proposal to publicize hepatitis rates of transfusion facilities. Finkelstein SN; Sapolsky HM Am J Law Med; 1979; 5(1):1-9. PubMed ID: 495608 [TBL] [Abstract][Full Text] [Related]
40. Removal and inactivation of hepatitis A virus (HAV) during processing of factor VIII concentrates. Hamman J; Zou J; Horowitz B Vox Sang; 1994; 67 Suppl 1():72-6; discussion 77. PubMed ID: 8091742 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]